Reproductive Health 2009 - Association of Reproductive Health
Transcription
Reproductive Health 2009 - Association of Reproductive Health
2009 Reproductive Health Education • Research • Advocacy 2007 Reproductive Health Education • Research Welcome to Reproductive Health 2009 September 30–October 3, 2009 | Los Angeles, CA • Advocacy 2History of the Reproductive Health Meeting 2About the Conference Partners 3 Welcome Letter 4 Learning Outcomes 4Concurrent, Accredited Pre-conference Sessions 5 Financial Disclosure Information 5 Accreditation 6 Conference Map 6How Do I Get My Continuing Education Credits for Reproductive Health 2009? 8 Special Assistance 8 Awards 9 Photo Authorization 10Faculty and Moderators 10 Lunch and Learn Facilitators 11 Oral Abstract Presenters 11 11 12 12 12 Discussants Planning Committee Host Committee Conference Staff Earthquake Preparedness 13 Exhibitors 13 Virtual Take One Table 14 Agenda at a Glance 16Confirmed Poster Presentations History of the Reproductive Health Meeting The powerful partnership behind this meeting is one of the key reasons that Reproductive Health is such a successful and popular conference. Planned Parenthood® Federation of America (PPFA) and the Association of Reproductive Health Professionals (ARHP) have hosted annual meetings together since the early 1960s. In 1999, the PPFA National Medical Committee (PPFANMC) and ARHP held their first joint conference in Dallas, Texas. The partnership proved to be a great fit, and the PPFANMC has coordinated with the Reproductive Health meeting for a decade now. The Society of Family Planning (SFP) was established in 2004 and joined the Reproductive Health partnership the following year. SFP brings a unique expertise in reproductive health research and scholarship to the partnership. Reproductive Health 2009 is the fifth annual meeting co-hosted by these three venerable organizations. About the Conference Partners The Association of Reproductive Health Professionals (ARHP) is a different kind of medical association. Our members define reproductive health in broad terms and recognize that the best health care is delivered through a team of professionals partnering with an informed patient. We are the association that brings together health care professionals across disciplines and specialties for evidence-based training and network building among committed colleagues. Our mission is education. ARHP produces accredited, evidence-based programs for health care professionals across a broad range of topics. ARHP members are passionate about science and demand rigorous standards for peer-reviewed data in educational programs and integrity in patient care. Planned Parenthood® Federation of America (PPFA) is the nation’s leading sexual and reproductive health care provider and advocate. PPFA provides comprehensive reproductive and related health care services, advocates public policies that support its mission, provides educational programs, and promotes research and technology in reproductive health care. PPFA’s National Medical Committee hosts its annual meeting as part of Reproductive Health 2009. Incorporated in 2004, the Society of Family Planning (SFP) is an academic society that advances family planning research and education. With more than 215 fellows, junior fellows, and candidate fellows, SFP seeks to cultivate a collaborative and supportive environment to foster scholarly activity among junior and experienced researchers. SFP also provides evidence-based clinical guidelines to improve health care in the areas of contraception and abortion, supplies expertise in the field with respect to scientific abstract review, and funds an annual research grants program for fellows committed to excellence in family planning research. 2 | Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA Dear friends and colleagues 2009 Reproductive Health Education • Research • Advocacy Welcome to Los Angeles, and thank you for being part of Reproductive Health 2009. The Association of Reproductive Health Professionals (ARHP), the National Medical Committee of Planned Parenthood® Federation of America (PPFANMC), and the Society of Family Planning (SFP) are proud of our continued partnership to bring you this unique meeting. Our goal is to deliver 2007 the combination of content and community that can’t be found at any other scientific meeting. Reproductive Health In many ways, it has been a tough year. We’ve mourned the loss of several luminaries in our field, including the devastating E d uinc athe t i ovirulent n • R e s debates e a r c h • over Advocacy murder of Dr. George Tiller. The right to safe abortion continues to be under attack, most recently health care reform. The struggling economy has affected all of us, heightening anxieties in our personal and professional lives. As the organizers of this longstanding meeting, it brings us great satisfaction that, despite the recession challenges, we are on track to have record attendance at this year’s conference. Thank you for your commitment to the Reproductive Health meeting as your community for learning, networking, support, and inspiration year after year. A few new and noteworthy features of Reproductive Health 2009: • Bigger and better. One of the major themes of this year’s meeting is more, more, more. In addition to our delightfully high attendance, we are featuring more scientific abstracts than ever before. You will find more than 90 poster abstracts on display in the exhibit hall, which is adjacent to the plenary room. We are also featuring more award winners speaking in the plenary sessions so all attendees can enjoy presentations from our five renowned honorees. • Streamlined system for evaluation and credit. We have instituted a more efficient and eco-friendly process for electronically gathering conference evaluations, facilitating claiming of continuing education (CE) credits, and distributing certificates. Post-conference, you will receive an e-mail with a link to the meeting evaluation. At the end of the evaluation, you will find a link directing you to claim your CE credits. Once you have claimed the number of credits commensurate with your participation, your certificate will arrive via e-mail in about four weeks. Voilà! • Reproductive Health is getting greener. In 2005, we launched our first “green conference” initiative and are proud to ramp up efforts in 2009 to put our eco-friendly values in practice. To further reduce the environmental impact of this meeting, we are no longer wasting reams of paper on printing a full syllabus for every attendee. Registrants can access the conference presentations online and choose what to print. Also, we are cutting back on plastic bottles and packaged lunches and promoting an extensive recycling effort. Be sure to submit your feedback and ideas on your evaluation to help us continue to reduce waste and conserve resources. Staff members from each partner organization are here to assist you and answer questions. You can find us at the registration desk, in attendance at every conference event, or wandering the exhibit hall wearing a name badge with a blue “staff” ribbon. Thank you for participating in Reproductive Health 2009 and for being a part of this passionate and committed community of reproductive health professionals. To a great meeting— Wayne C. Shields President and CEO, ARHP Vanessa Cullins, MD, MPH, MBA Vice President for Medical Affairs, PPFA Susan Higginbotham, MEd Executive Director, SFP Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 3 learning outcomes At the conclusion of Reproductive Health 2009, participants should be able to: •Demonstrate newly acquired knowledge, understanding, and skills when diagnosing and treating men, women, and adolescents for reproductive health conditions Concurrent, Accredited Pre-conference Sessions Emerging Topics in Adolescent Health At the conclusion of this educational session, participants should be able to: • Navigate the Web-based resource for teens, www.Thatsnotcool.com, to address textual harassment and the digital line • Navigate the Web-based resource for teens and young adults, www.kNOwmoresaymore.org, to address reproductive control • Identify key factors influencing risky decision making during adolescence • Identify key data concerning risky adolescent behavior • Identify current models and theories explaining risk taking in adolescence, with an emphasis on fuzzy-trace theory • Empirically list supported recommendations for policy and practice in reducing risky adolescent behavior IUC: Standard Insertion and Special Cases •Impart improved guidance to patients on general reproductive health and family planning, including lessons learned from scientific research in the United States and abroad At the conclusion of this session, participants should be able to: •Demonstrate effective communication and counseling skills about reproductive health with patients and patients’ families • Discuss strategies for management and follow-up after IUD insertion •Incorporate an awareness of current social, political, and legal issues affecting reproductive health care into professional practice • Describe clinical presentation and management strategies for chlamydia, gonorrhea, and their • Name the two forms of intrauterine contraception currently available in the United States • State efficacy associated with intrauterine contraception compared with other contraceptive methods • List selection criteria for appropriate candidates for intrauterine contraception • Identify two possible side effects of intrauterine contraception • Provide pain management for adolescents and nulligravidas during IUD insertion • Use special techniques to visualize and access the cervix when needed • Appropriately select patients for IUC after spontaneous or induced abortion Case Studies on Sexually Transmitted Infections in Women At the conclusion of this session, participants should be able to: • Identify key patient information to be obtained in a sexual history and develop skills to obtain this information in an age-appropriate, culturally competent manner related syndromes of cervicitis and pelvic inflammatory disease • Properly differentiate causes of abnormal vaginal discharge • List three new developments in managing genital herpes and HPV-associated disease • Apply simple approaches to implementing client-centered risk-reduction counseling 4 | Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA Financial Disclosure Information Faculty and Moderators Bailey: Consultant for Bayer, Schering-Plough Berarducci: Receives grants/research support from Proctor & Gamble; is a speaker for Sanofi-Aventis Creinin: Speaker for Schering-Plough Mishell: Consultant for Bayer, Schering-Plough, and Teva Rodriguez: Speaker for Duramed and Schering-Plough Shulman: Receives grants/research support from Bayer; is a consultant for Schering-Plough, Duramed, and Ortho; and is a speaker for Bayer, Schering-Plough, Duramed, and Ortho Bauer, Camp, Clark, Córdoba, Darroch, Espey, Estrada, Finer, Fjerstad, Gabelnick, Garcia, Gilbert, Gilliam, Godfrey, Guerry, Haider, Harper, Harris, Hatcher, Hathaway, Janssen, Joffe, Jones, Jordan, Kulberg, Levenson, Lindahl, Low Dog, Madsen, Miller, Russo, Shen, Speidel, Stern, Trussell, and Winikoff have no financial interests or affiliations to disclose. Oral Abstract Presenters Postlethwaite: Receives grants/research support from Bayer Westhoff: Receives grants/research support from Duramed; is a consultant for Duramed, Bayer, and Schering-Plough Blum, Dean, Dehlendorf, Dennis, Graseck, Grossman, Harper, Jones, Perriera, Pittman, Racek, Sietstra, and Soliman have no financial interests or affiliations to disclose. Oral Abstract Discussants: Drey: Speaker for Schering-Plough Goodman: Speaker for Schering-Plough Kaunitz: Receives grants/research support from Ortho, Medical Diagnostic Laboratories, Schering-Plough, Proctor & Gamble, and Teva; is a speaker and/ or consultant for Bayer, Ortho, Merck, Schering-Plough, Proctor & Gamble, and Teva; owns stock/is a shareholder in Becton Dickinson and Sanofi-Aventis Lichtenberg: Owns stock/is a shareholder in Family Management Inc. and Burlington Commercial Insurance Company Turok: Receives grants/research support from Duramed; is a speaker for Schering-Plough Westhoff: Receives grants/research support from Duramed; is a consultant for Duramed, Bayer, and Schering-Plough Fjerstad, Foster, Godfrey, Goldberg, Hammond, Harwood, Kottke, Teal, and Trussell have no financial interests or affiliations to disclose. Planning Committee Gilliam: Receives grants/research support from Schering-Plough Kaneshiro: Receives grants/research support from Wyeth; is a consultant for IPAS Deal, Downing, Espey, Fjerstad, Gordon, Haider, Hammond, Hathaway, Higginbotham, Huggins, Jordan, Kulberg, Lindahl, Moos, Rubin, Schwimmer, Shea, Stern, and White have no financial interests or affiliations to disclose. ARHP Staff Brenner, C. Brown, S. Brown, Challender, Cohen, Drahan, Everitt, Glispie, Gordon, Harris, Henry, Kennedy, Jordan, Korman, March, Riessman, Robbins, Sager, Shields, Sowecke, Swann, and Tyler have no financial interests or affiliations to disclose. PPFA Staff Cullins, Debevec, Eldredge-Martin, Graziani, Majkowski, Morfesis, Nucatola, Talmont, and Worthington: Receive grants/research support from Merck, GSK, Hologic, QIAGEN, Orasure, Graceway, Ortho, Wyeth, Watson, and HRA-Pharma; on the advisory board for Schering-Plough, Ortho Shea and Wilhelm have no financial interests or affiliations to disclose. SFP Staff Higginbotham, Polonsky, and Sot have no financial interests or affiliations to disclose. Accreditation Nurse-Midwives Physician Assistants AMA PRA Category 1 Credits™ are accepted by the Continuing Competency Assessment Program of the American College of Nurse-Midwives for programs relevant to nurse-widwifery. The American Academy of Physician Assistants accepts AMA PRA Category 1 Credits™ towards AAPA CME credit. Nurse Practitioners This educational activity will be approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women’s Health. It is estimated that NPWH will designate 14.5 contact hours for the general conference, including 7 pharmacology hours, and 3.5 contact hours for each pre-conference session, including 1 pharmacology hour. Pharmacists The Association of Reproductive Health Professionals (ARHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Physicians The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Pre-conference Sessions The Association of Reproductive Health Professionals designates this educational activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This activity has been reviewed and is acceptable for up to 3.50 Prescribed credits by the American Academy of Family Physicians. Pre-conference Sessions This program provides 3.5 (.35 CEUs) contact hours of continuing pharmacy education credit as recognized by the Accreditation Council for Pharmacy Education. The assigned universal program number for RH 2009 pre-con: IUC: Standard Insertion and Special Cases is 0463-0000-09-018-L04-P; RH 2009 pre-con: Case Studies on Sexually Transmitted Infections in Women is 0463-0000-09-019-L04-P; RH 2009 pre-con: Emerging Topics in Adolescent Health is 0463-0000-09-020-L04-P. Each pharmacist must complete the post-test to receive credit for this activity. General Conference The Association of Reproductive Health Professionals designates this educational activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. General Conference This program provides 14.5 (1.45 CEUs) contact hours of continuing pharmacy education credit as recognized by the Accreditation Council for Pharmacy Education. The assigned universal program number is 0463-0000-09-021-L04-P. Each pharmacist must complete the post-test to receive credit for this activity. ARHP has applied for ACOG cognate hours (Formal Learning). This activity has been reviewed and is acceptable for up to 14.50 Prescribed credits by the American Academy of Family Physicians. Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 5 conference map How Do I Get My Continuing Education Credits for Reproductive Health 2009? A more efficient and eco-friendly process is now in place for electronically gathering conference evaluations, facilitating participants’ claiming of continuing education (CE) credits, and distributing certificates. To Receive Your CE Certificate for the General Conference: • Immediately following the meeting, check your e-mail for a message from the conference staff • Click on the link provided and complete the conference evaluation • At the end of the evaluation, click on the link directing you to claim your CE credits. Participants should only claim credit commensurate with the extent of their participation in the activity. You must claim the actual number of credits in order to receive CE credit and a certificate • Your CE certificate will be delivered via e-mail within 4 weeks of the meeting To Receive Your CE Certificate for a Pre-conference Session: • At the conclusion of your pre-conference session, complete the evaluation and claim your credits • Your pre-conference CE certificate will be delivered via e-mail within 4 weeks of the pre-conference 6 | Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 7 Special Assistance The Reproductive Health 2009 staff wishes to ensure that no individual with a disability is excluded, denied services, segregated, or otherwise treated differently from other individuals because of the absence of auxiliary aids or services identified in the Americans with Disabilities Act. Please notify us of your needs at the registration desk on the Mezzanine level. awards Cushner Lectureship Imagining Change: The Role of Science in Getting from Here to There Beverly Winikoff, MD, MPH Thursday, October 1, 8:00 am The Cushner Lectureship honors Irvin M. Cushner, MD, MPH, an influential leader in the fields of modern reproductive health care and public health and a true champion of reproductive rights and social welfare in the United States. The award is given annually to a layperson, public figure, or health care professional who has helped raise awareness of health public policy issues. The lecture addresses a pressing issue in the field of health care, especially as it may pertain to reproductive health. The Lifetime Achievement Award for Family Planning A Century of Contraceptive Use in America: Lessons from the Past, Challenges of the Future Jacqueline E. Darroch, PhD Thursday, October 1, 2:00 pm The Award for Lifetime Contributions in Family Planning was created in 2005 by the Society of Family Planning. The award is presented annually to honor those outstanding individuals whose cumulative research has reached the highest level of importance in the field. Recipients of this award have devoted their scientific and medical careers to the furtherance of women’s reproductive choice and health. This year, the Society of Family Planning is pleased to present this award to Jacqueline E. Darroch, PhD, an independent researcher in social demography and senior fellow at the Guttmacher Institute, where she has been involved since 1978. 8 | Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA Allan Rosenfield Award for Lifetime Contributions to International Family Planning Family Planning: Progress, Lessons Learned, and the Unfinished Agenda J. Joseph Speidel, MD, MPH Thursday, October 1, 2:30 pm The Society of Family Planning is delighted to present the third annual Allan Rosenfield Award for Lifetime Contributions to International Family Planning. This award was created to pay homage to the exceptional research, authority, and dedication of its namesake and first recipient, Dr. Allan Rosenfield, and to his invaluable contributions to the health of women worldwide. This year, the award will be presented to J. Joseph Speidel, MD, MPH, professor, Department of Obstetrics, Gynecology and Reproductive Sciences and director for communication, development, and external relations at the Bixby Center for Global Reproductive Health, University of California, San Francisco. Guttmacher Lectureship The Challenge of Providing Dual Protection Henry L. Gabelnick, PhD Friday, October 2, 8:00 am Alan F. Guttmacher, MD, was an obstetrician/gynecologist who devoted his career to the social and medical welfare of women and minorities. Dr. Guttmacher saw medicine as a profession that should contribute to the solution of society’s problems and was known as a humanist with a strong social conscience. In his honor, ARHP created the Guttmacher Lectureship, awarded each year to a health care provider or scientist who has been a major contributor to the field of reproductive health. The lecture addresses a major scientific advancement that has significant reproductive health resonance in both the scientific and medical communities. Photo Authorization By attending Reproductive Health 2009, you acknowledge that you may appear in photographs taken by conference staff. All conference photographs are eligible for promotional use at the discretion of the conference staff. Photographs posted to the conference Web site and Conference Photo Gallery (via Flickr) will be removed upon request. Burnhill Lectureship When Does Personhood Begin? The Biology and the Rhetoric Scott F. Gilbert, MA, PhD Saturday, October 3, 8:00 am This annual award honors Michael S. Burnhill, MD, DMSc, who served as Planned Parenthood® Federation of America’s (PPFA) vice president for medical affairs and was a founding member of ARHP. Dr. Burnhill was instrumental in linking ARHP with the PPFA National Medical Committee and promoted their collaboration of joint sessions at this annual meeting. In honor of Dr. Burnhill, PPFA and ARHP established the Michael S. Burnhill Memorial Lectureship, which honors his legacy with a presentation emphasizing innovation and leadership in the field of women’s reproductive health. Sylvia Clark Award Virginia League for Planned Parenthood Presented at the PPFA National Medical Conference Luncheon Saturday, October 3, 1:00 pm The Sylvia Clark Award: Creativity in Clinical Services is presented annually at the PPFA National Medical Conference to honor the clinical services provider (or team) from a Planned Parenthood affiliate who, through her or his creativity, has demonstrated commitment to Planned Parenthood’s vision and mission. Pioneer and Leader Award Planned Parenthood of the Heartland Gary Stewart Scholarship for Research in Public Health Kristen Shellenberg, MPH Presented at the Poster and Awards Reception on Friday, October 2, 4:00 pm Presented at the PPFA Clinical Issues Presentation Saturday, October 3, 9:45 am The Pioneer and Leader Award was created in 2004. The award is given to an affiliate that demonstrates exemplary leadership in pioneering a new technology or strategy for accomplishing the Planned Parenthood mission. ARHP launched the Stewart Scholarship seven years ago to honor the memory and contributions of Gary Stewart, MS, MPH, to the field of reproductive health. Dr. Stewart was a leading international medical educator and advocate who served as a mentor to countless rising public health professionals. This award goes to an outstanding public health graduate student working on research projects to address current issues in the field of public health, especially as it may pertain to reproductive health. Miriam Manisoff Award Victoria C. Fletcher, RN, MSN, CNM, FACNM Planned Parenthood of the Great Northwest Presented at the PPFA National Medical Conference Luncheon Saturday, October 3, 1:00 pm The Miriam Manisoff Award was established in 1982 in recognition of Ms. Manisoff, a true leader, who started the PPFA nurse practitioner program. PPFA carries on this tradition by honoring an advanced practice clinician employed by a Planned Parenthood affiliate who has demonstrated a significant contribution to the advancement of the roles of advanced practice clinicians in the areas of clinical practice, scholarship, and/or leadership. Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 9 Faculty and Moderators Lynn Bailey, PhD University of Florida Gainesville, FL Heidi M. Bauer, MD, MS, MPH STD Control Branch Richmond, CA Adrienne Berarducci, PhD, ARNP, BC University of South Florida Tampa, FL Talcott Camp, JD ACLU Reproductive Freedom Project New York, NY Barbara J. B. Clark, MPAS, PA-C Knox OB/GYN, Ltd. Galesburg, IL Rocio L. Córdoba, JD California Latinas for Reproductive Justice Los Angeles, CA Mitch Creinin, MD Magee-Womens Hospital Pittsburgh, PA Jacqueline E. Darroch, PhD Guttmacher Institute New York, NY Eve Espey, MD, MPH University of New Mexico Albuquerque, NM Steven Estrada Cornell University Ithaca, NY Lawrence Finer, PhD Guttmacher Institute New York, NY Mary Fjerstad, NP, MHS Ipas Chapel Hill, NC Henry L. Gabelnick, PhD CONRAD Arlington, VA Francisco A. R. Garcia, MD, MPH University of Arizona National Center of Excellence in Women’s Health Tucson, AZ Scott F. Gilbert, MA, PhD Swarthmore College Swarthmore, PA Melissa Gilliam, MD, MPH University of Chicago Chicago, IL Emily Godfrey, MD, MPH University of Illinois, Chicago Chicago, IL Sarah L. Guerry, MD L.A. County Sexually Transmitted Disease Program Los Angeles, CA Sadia Haider, MD, MPH Harvard Medical School Boston, MA Cynthia Harper, PhD University of California, San Francisco San Francisco, CA Lisa Harris, AB, MD, PhD University of Michigan Ann Arbor, MI Robert A. Hatcher, MD, MPH Emory University School of Medicine Atlanta, GA Mark Hathaway, MD, MPH Washington Hospital Center Washington, DC Sarah Janssen, MD, PhD, MPH University of California, San Francisco San Francisco, CA Carole Joffe, PhD University of California, San Francisco San Francisco, CA Kirtly Jones, MD University of Utah Medical Center Salt Lake City, UT Beth Jordan, MD Association of Reproductive Health Professionals Washington, DC Heidi A. Kulberg, MD, MPH Planned Parenthood of Southeastern Virginia Norfolk, VA Rebecca Levenson, MA Family Violence Prevention Fund San Francisco, CA Sarah H. Lindahl, MS, PA-C Association of Physician Assistants in Obstetrics and Gynecology Walnut Creek, CA Tieraona Low Dog, MD Arizona Center for Integrative Medicine Tucson, AZ Allegra Madsen ISIS, Inc. Oakland, CA Elizabeth Miller, MD, PhD UC Davis School of Medicine Sacramento, CA Daniel R. Mishell, Jr., MD University of Southern California Los Angeles, CA 10 | Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA Patricia Aikins Murphy, CNM, DrPH, FACNM University of Utah College of Nursing Salt Lake City, UT Pablo Rodriguez, MD Warren Alpert Medical School at Brown University Pawtucket, RI Nancy Felipe Russo, PhD Arizona State University Tempe, AZ Eveline Shen, MPH Asian Communities for Reproductive Justice Oakland, CA Lee P. Shulman, MD Northwestern University Chicago, IL J. Joseph Speidel, MD, MPH University of California, San Francisco San Francisco, CA Lisa Stern, APRN Planned Parenthood Los Angeles Los Angeles, CA James Trussell, BPhil, PhD Princeton University Princeton, NJ Chris Wilkinson, MBBS, FFFP Margaret Pyke Centre London, England Beverly Winikoff, MD, MPH Gynuity Health Projects New York, NY Lunch and Learn Facilitators Kelly Blanchard, MSc Ibis Reproductive Health Cambridge, MA Charlotte Brody Safer Chemicals, Healthy Families Esmont, VA Todd Buchacker, RN Planned Parenthood of the Heartland Des Moines, IA Penny Dickey Planned Parenthood of the Heartland Des Moines, IA Mary Fjerstad, NP, MHS Ipas Chapel Hill, NC Daniel Grossman, MD Ibis Reproductive Health Oakland, CA Susan Higginbotham, MEd Society of Family Planning Philadelphia, PA Bethany Holt, PhD, MPH California Microbicide Initiative Berkeley, CA Corinna Lohser, MPH Spence Chapin Services New York, NY Tessa Madden, MD, MPH Washington University School of Medicine St. Louis, MO Cristina Page Spence Chapin Services New York, NY Sarah Prager, MD, MAS University of Washington Seattle, WA Matt Reeves, MD, MPH CONRAD Arlington, VA Wayne C. Shields Association of Reproductive Health Professionals Washington, DC James Trussell, BPhil, PhD Princeton University Princeton, NJ Leah Weber, LBSW, CADC, MA, NCC Avalon Center Mason City, IA Christopher White, PhD, CHES National Sexuality Resource Center, SFSU San Francisco, CA Oral Abstract Presenters Jennifer Blum, MPH Gillian Dean, MD, MPH Christine Dehlendorf, MD, MAS Amanda Dennis, MBE Anna Graseck, BA Daniel Grossman, MD Cynthia Harper, PhD Rachel Jones, PhD Lisa Perriera, MD, MPH Meredith Pittman, BA Debbie Postlethwaite, RNP, MPH Christina Racek, BS Cari Sietstra, JD Evelen Soliman, DO Carolyn Westhoff, MD, MSc Discussants Eleanor Drey, MD, EdM Mary Fjerstad, NP, MHS Angel Foster, MD, DPhil, AM Emily Godfrey, MD, MPH Alisa Goldberg, MD, MPH, FACOG Suzanne Goodman, MD, MPH Cassing Hammond, MD Bryna Harwood, MD, MSc Andrew Kaunitz, MD, FACOG Melissa Kottke, MD E. Steve Lichtenberg, MD, MPH Stephanie Teal, MD, MPH James Trussell, BPhil, PhD David Turok, MD, MPH Carolyn Westhoff, MD, MSc Planning Committee Melanie Deal, MSN, WHNP-BC, FNP San Francisco State University San Francisco, CA Don Downing, RPh Department of Pharmacy University of Washington Seattle, WA Eve Espey, MD, MPH Department of Obstetrics and Gynecology University of New Mexico Albuquerque, NM Mary Fjerstad, NP, MHS Ipas Chapel Hill, NC Melissa Gilliam, MD, MPH Department of Obstetrics and Gynecology University of Chicago Chicago, IL Teresa Gipson, MD Department of Family Medicine Oregon Health Sciences University Portland, OR Rivka Gordon, PA-C, MHS Association of Reproductive Health Professionals Oakland, CA Sadia Haider, MD, MPH (Co-chair) Department of Obstetrics and Gynecology Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA Cassing Hammond, MD Northwestern University Feinberg School of Medicine Chicago, IL Mark Hathaway, MD, MPH Washington Hospital Center Washington, DC Susan Higginbotham, MEd Society of Family Planning Philadelphia, PA George R. Huggins, MD (Co-chair) Department of Obstetrics and Gynecology Johns Hopkins University School of Medicine Baltimore, MD Beth Jordan, MD Association of Reproductive Health Professionals Washington, DC Bliss Kaneshiro, MD, MPH University of Hawaii Honolulu, HI Heidi A. Kulberg, MD, MPH Planned Parenthood of Southeastern Virginia Norfolk, VA Sarah H. Lindahl, MS, PA-C Association of Physician Assistants in Obstetrics and Gynecology Walnut Creek, CA Merry-K. Moos, RN, FNP, MPH, FAAN Department of Obstetrics and Gynecology University of North Carolina Chapel Hill, NC Susan E. Rubin, MD, MPH Department of Family and Social Medicine Albert Einstein College of Medicine/ Montefiore Medical Center Bronx, NY Cecily Schwimmer, CNM, NP, MS Planned Parenthood of New York City New York, NY Karen Shea, MSN, WHNP-BC Planned Parenthood Federation of America New York, NY Lisa Stern, APRN Planned Parenthood Los Angeles Los Angeles, CA Christopher White, PhD, CHES National Sexuality Resource Center San Francisco State University San Francisco, CA Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 11 Host Committee Susan A. Ballagh, MD Department of Obstetrics and Gynecology Harbor-UCLA Medical Center Torrance, CA Carla Blieden, PharmD, MPH Los Angeles, CA Mary Gatter, MD Planned Parenthood Los Angeles Los Angeles, CA Paige Hardin, RNC, MN, NP Planned Parenthood Los Angeles Los Angeles, CA Alan Kaye National Cervical Cancer Coalition West Hills, CA Daniel R. Mishell, Jr., MD University of Southern California Keck School of Medicine Los Angeles, CA Anita Nelson, MD Harbor-UCLA Medical Center Los Angeles, CA Deborah Nucatola, MD Planned Parenthood Los Angeles Los Angeles, CA Sally Rafie, PharmD University of California San Diego Medical Center San Diego, CA Penina Segall-Gutierrez, MD, MSc Department of Obstetrics and Gynecology LAC+USC/Keck School of Medicine Los Angeles, CA Blair Tatton, MSPA-C Planned Parenthood Los Angeles Los Angeles, CA DeShawn Taylor, MD University of Southern California Keck School of Medicine Los Angeles, CA Norma Jo Waxman, MD Department of Family and Community Medicine University of California, San Francisco San Francisco, CA Conference Staff ARHP Matt Brenner, MPH Program manager Carrie Brown, MBA, MS, MPH Education associate Shana Brown, MPH Associate director of development Megan Challender Education associate Ellen L. Cohen, CertEd, DipEd, CCMEP Director of education Stephanie L. Drahan Communications associate Shelby Everitt Conference and education manager Jeff Glispie Information technology associate Rivka Gordon, PA-C, MHS Director of strategic initiatives Camille V. Harris, MPH Program manager Delysha D’Mellow Henry, MPH Program manager Aleya Horn Kennedy, MPP Education associate Beth Jordan, MD Medical director Allison Tombros Korman, MHS Associate director of education Martha March, MBA Operations associate Janet Riessman Director of communications Beth Robbins, MBA Associate director of communications Rebecca Sager Director of development Wayne C. Shields President and chief executive officer Elisabeth Sowecke Membership associate Amy M. Swann, MA Vice president of operations Candace Tyler Administrative assistant PPFA Vanessa E. Cullins, MD, MPH, MBA Vice president, medical affairs Elie Debevec Project specialist, continuing medical education and special projects Penni Eldredge-Martin, CIPM Director, PPFA national office and event security Vikky Graziani Project specialist, clinical services Jesse Karch Consultant, clinical services Tina Majkowski Project specialist, research department Johanna Morfesis, MSN, WHNP-BC Director, research department Deborah Nucatola, MD Senior director, clinical services Karen Shea, MSN, WHNP-BC Director, clinical services Elizabeth Talmont, MSN, NP Director, service delivery and training, CAPS Melissa Wilhelm Manager of operations, office of the COO Sandy Worthington, MSN, WHNP-BC, CNM Director, continuing medical education and special projects SFP Susan Higginbotham, MEd Executive director Marlo Polonsky, MPH Grants officer Sarom Sot Administrative coordinator Drop! Cover! Hold on! Protect yourself during earthquake shaking Do not head for the doorway. In modern buildings, doorways are no stronger than any other part of the building. You are safer taking cover under a sturdy table or desk. 12 | Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA Exhibitors Exhibits will be open all day Thursday and Friday Platinum Boehringer Ingelheim GOLD Bayer HealthCare Pharmaceuticals Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc. Hologic LP Merck and Company, Inc. Ortho Woman’s Health & Urology™ SILVER LabCorp GENERAL/NONPROFIT Association of Physician Assistants in Obstetrics and Gynecology Association of Reproductive Health Professionals Basic Health International, Inc. Boulder Abortion Clinic California Family Health Council California Office of Family Planning, Family PACT Conceptus, Inc. Danco Laboratories, LLC Elsevier Family Violence Prevention Fund Focus Diagnostics GlaxoSmithKline GYN Disposables, Inc. Healthy Teen Network HPSRx Enterprise, Inc. Lippincott Williams & Wilkins MedGyn Midwest Access Project — Reproductive Health Access Project Moore Medical National Abortion Federation National Association of Nurse Practitioners in Women’s Health National Cervical Cancer Coalition National Family Planning and Reproductive Health Association Office of Population Affairs Clearinghouse Pearl of Wisdom Pfizer, Inc. Pharmacy Access Partnership — Pacific Institute of Women’s Health Planned Parenthood® Federation of America Ryan Residency Training Program Society of Family Planning SUPPORTERS Bayer HealthCare Pharmaceuticals Endo Pharmaceuticals, Inc. GlaxoSmithKline Graceway Pharmaceuticals Merck and Company, Inc. Passport Foundation Pfizer, Inc. QIAGEN Richard and Rhoda Goldman Fund Wyeth Pharmaceuticals virtual take one table As Reproductive Health goes green, we invite you to check out our eco-friendly “take one” table at www.ReproductiveHealth2009.org. Resources provided by: California Family Health Council Endometriosis Research Center Exhale Jacobs Institute of Women’s Health Organization of Teratology Information Specialists (OTIS) Looking for a comfortable and private place to pump or nurse? Visit the dedicated lactation room in Suite 329. Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 13 2009 Reproductive Health Education • Research • Advocacy Agenda at a glance 2007 Reproductive Health Education • Research • Advocacy Thursday 10/01 Wednesday 9/30 Concurrent, Accredited Pre-conference Sessions Afternoon Exhibits and posters set up all day in Salons 3–6 Morning Plenary Session I SFP’s Career Development Seminar: Designing and Performing Studies Using Survey Data Concurrent Lunch and Learn Sessions Afternoon ARHP Board Meeting and Dinner Evening Continental Breakfast with Exhibitors Plenary Session II ARHP Membership Meeting SFP Board Meeting and Dinner SFP Business Meeting Welcome Reception SFP Reception (SFP Fellows and Junior Fellows only) Evening National Patient Services Council Reception (Planned Parenthood staff/volunteers only) SFP Dinner (SFP Fellows, Junior Fellows, and guests only) Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 14 Reproductive Health 2009 9/30 Wednesday 10/01 Thursday Additional PPFA Events 10/02 10/03 10/04 Friday Saturday Sunday Friday 10/02 Exhibits and posters set up all day in Salons 3–6 Saturday 10/03 Continental Breakfast with Exhibitors Morning Sunday 10/04 Continental Breakfast Continental Breakfast Telemedicine Update Late Breaking Reproductive Health Updates Plenary Session III Plenary Session IV National Medical Committee Members and Liaison Luncheon (by invitation only) PPFA Clinical Issues Discussions, Part II (Planned Parenthood staff/ volunteers only) Morning PPFA/ARMS Clinicians’ Lunch (Planned Parenthood staff/volunteers only) Morning NMC subcommittee presentations, reports, and final discussions (Planned Parenthood staff/volunteers only) PPFA National Medical Conference concludes Concurrent Breakout Session III Corporate Advisory Board lunch Reproductive Health 2009 concludes Lunch with Exhibitors Afternoon PPFANMC Subcommittee Meetings (Planned Parenthood staff/volunteers only) Concurrent Breakout Session I PPFANMC Subcommittee Meetings (continued) PPFA Clinical Issues Discussions, Part I (Planned Parenthood staff/volunteers only) Concurrent Breakout Session II Afternoon New Medical Directors’ Orientation (Planned Parenthood medical directors only) Poster and Awards Reception and Book Signing Evening Medical Directors Council (MeDC) Meeting (Planned Parenthood medical directors only) PPFANMC Luncheon and Sylvia Clark Award Presentation (Planned Parenthood staff/volunteers only) Evening PPFANMC Dr. George Tiller Memorial Reception (Planned Parenthood staff/volunteers only) MeDC Dinner (Planned Parenthood medical directors only) Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 15 Confirmed Poster Presentations Posters will be displayed all day Thursday, October 1 and Friday, October 2 P1 Women Seeking Abortion Underreport Gestational Age by an Average of 1 Week Based on Last Menstrual Period Compared to Ultrasound Dating P2 Advanced Practice Clinicians As Abortion Providers: Preliminary Findings from the California Primary Care Initiative P3 Outpatient Surgical Miscarriage Management: Current Practice among Family Medicine Residents and Faculty in Washington State P26 Does Emergency Contraception Choice Impact Effective Contraception 1 Month Later? A Prospective Comparison of the Copper IUD and Oral Levonorgestrel P27 A Survey of Women Obtaining Emergency Contraception: Are They Willing to Use the Copper IUD? P28 Postpartum Contraception: Needs vs. Reality P4 Patterns of Contraceptive Use Before and After an Abortion: Results from a Large Nationally Representative Survey of Women Undergoing an Abortion in France P29 Two-week Postpartum Implanon Insertion Is Not Equivalent to Immediate Postpartum LARC P5 Changes in Fertility among Young Ethiopian Immigrants in Israel: Abortion Levels Over a Decade P31 Providing Contraception and Contraceptive Counseling to Adolescents: Perspectives of Residents from Three Specialties P30 Pilot Study of Vaginal Estrogen Supplementation during DMPA Initiation P6 Impact of Formal Family Planning Training on Ob/Gyn Residents’, Skills in Uterine Aspiration and Contraception Provision P32 Preferences for Decision Making about Contraception among Healthy Adult Women P7Providing Contraception to Patients in the Abortion Care Setting: Practices and Barriers P33 The Post Abortion Progestin Contraception Study: Which Demographic Factors Predict Choice of Long-acting, Reversible Contraception? P8 Abortion Training in Ob/Gyn Residency Programs: Results of a National Survey P34 Duration of Breastfeeding Is Similar in Postpartum Women Using Combination Oral Contraceptives Compared to Those Using Progestin-only Oral Contraceptives P9 Digoxin-induced Fetal Death Increases Surgeon-perceived Ease of Second-trimester Surgical Abortion P10 Second-trimester Abortion Technique Study: A Prospective Cohort Study P35 Barriers to Uptake of the Intrauterine Device (IUD) among Postpartum African American Adolescents P11 Influence of Induced Abortion Training on Attitudes and Treatment Patterns for Early Pregnancy Failure P36 Time to Pregnancy in a Cohort of Low-income, Urban Latinas: Does Diabetes Matter? P12 Safety of Relative High-dose Vasopressin as a Cervical Block in Dilation and Evacuation P37 A Multi Center Randomized Controlled Feasibility Trial of Levonorgestrel-releasing Intrauterine System Compared to the Copper T380A among Adolescents Ages 14-18 P13 Postpartum Family Planning Needs Assessment in Cap Haitien, Haiti P14 Contraceptive Use, Recall and Barriers P15 Incomplete and Failed Abortion Following Immediate or Delayed Postaspiration IUD Insertion P16 Immediate Intrauterine Device Insertion Following Suction Aspiration Between 5 and 12 Weeks’ Gestation Increases Rates of Insertion and Utilization Compared to Scheduled Delayed Insertion P17 US Family Physicians’ Knowledge, Attitude and Practice With Intrauterine Contraception P18 Provision of Contraceptive Services to Diabetic Women of Reproductive Age P19 Cycle Control with a 21- vs. a 24-Day Oral Contraceptive Regimen: Influence of Previous Hormonal Exposure P20 Provision of Family Planning Services to Female Veterans Prescribed Teratogenic Medications P21 Breastfeeding Continuation among Women Using the Levonorgestrel-releasing Intrauterine Device After Vaginal Delivery P22 A Randomized Trial of Postplacental Compared to Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device After Vaginal Delivery P23 Outcomes of Transcervical Hysteroscopic Sterilization in an Urban Academic Medical Center P24 Trends in Tubal Sterilization and Intrauterine Device Uptake at an Urban Academic Medical Center P25 Differences in Knowledge May Contribute to Racial Variation in Tubal Sterilization Rates Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 16 P38 Immediate versus Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device Following Dilation and Evacuation: A Randomized Controlled Trial P39 “Why Does My Partner Feel Strings?” and Other Questions Posed by Women Who Had IUC Placed After Their Abortions P40 Uterine Infection Following Immediate or Delayed Post-aspiration Intrauterine Device (IUD) Insertion P41 Ovarian Suppression during Oral Contraceptive Use in Normal-weight and Obese Women P42Intrauterine Contraception for Adolescents: Where Are the Pediatricians? P43 Patterns of Long-term Contraceptive Methods and Depo-provera Use among Women Attending Korle-Bu Teaching Hospital, Accra P44 Injectable Contraception Use among Salvadoran Women: An In-depth Analysis of Attitudes and Experiences P45 Trends and Determinants of Hormonal Contraceptive Use among HIV-infected Women in Rakai, Uganda, 1994-2005 P46 Malpositioned IUDs: Risk Factors, Outcomes and Future Pregnancies P47 Determinants of Early Contraceptive Discontinuation for Method-related Reasons: Results from a Population-based Cohort of French Women P48 Contraceptive Counseling and Utilization in Women Who Underwent Bariatric Surgery P49 Levonorgestrel Intrauterine System and Medroxyprogesterone Acetate for Treatment of Heavy Menstrual Bleeding Confirmed Poster Presentations Posters will be displayed all day Thursday, October 1 and Friday, October 2 P50 Unmarried Young Adults’ Contraceptive Knowledge and Attitudes P51 Recommendations for Long-acting Reversible Contraception: How Do the Race/Ethnicity and Socioeconomic Status of Patients Affect Providers’ Decisions? P52 Women’s Perceptions of Advantages and Disadvantages of Moving Oral Contraceptives Over the Counter P53 Introduction of Post Placental/Partum IUD Insertion in Lusaka, Zambia: Feasibility of Training Nurse Midwives P54 Need for Emergency Contraception among Female Patients Seeking Sexually Transmitted Infection Clinical Services in a Public Health Setting P55 Effects of Patch versus Oral Contraception on Coagulation Factors: A Randomized Crossover Study P56 Contraceptive Counseling and Ambivalence Towards Pregnancy in Primary Care Settings P57 Maintenance of Confidence in IUD Counseling and Insertion After Incorporating Didactic Teaching and IUD Insertion Techniques into the Third Year Medical Student Gynecologic Skills Workshop P58 Effectiveness of an Extended-regimen Oral Contraceptive for the Treatment of Moderate to Severe Pelvic Pain in Adolescents P59 Disparities in IUD Use between Physicians and Non Physicians: A Survey of IUD Use in a Large University Population P60 IUD-related Knowledge and Attitudes amongst Women’s Healthcare Providers in El Salvador P61 Knowledge of Intrauterine Contraception: A Survey of Women in the St. Louis Region P62 Pregnancy Intention and Contraceptive Decision-making P63 Effects of Ethinylestradiol and Estradiol on Oxidative Stress and Nitric Oxide Synthesis in Immortalized Human Endothelial Cell Line ECV304 P64 Changes in Insulin Sensitivity and B-Cell Responsiveness in Obese Women Using Depomedroxyprogesterone Acetate P65 Chlormadinone Acetate 2mg/Ethinylestradiol 0.03mg Did Not Impair Vascular Function in Healthy Women P66 Contraceptive Practices among Adolescents Who Experienced an Unintended Birth P67 Hormonal Contraceptive Method Choice among Young Low-income Women: How Strong is the Provider Effect? P68 Failure to Return for Intrauterine Device Insertion After Initial Clinic Visit P69 Association between Intrauterine Contraception and Pelvic Inflammatory Disease: An Analysis of the 2002 National Survey of Family Growth P70 Access and Barriers to Reversible Contraception among Recently Arrested Women in San Francisco P71 Within-cycle Variation in Coagulation Factors Seen with Patch and Oral Contraception: A Randomized Crossover Study P72 A Randomized Controlled Trial of the Impact of Advanced Supply of Emergency Contraception on Postpartum Teens P73 Are Tampon Users More Likely to Choose the Contraceptive Vaginal Ring than Combined Oral Contraceptives? P74 The Association of Clients’ Experiences at Their First Family Planning Visit and Their Perceptions of Service Quality P75 Contraceptive Use among Women on a Tanzanian Sugar Plantation P76 Contraceptives in College: Undergraduates’ Usage Patterns and Attitudes Toward Pregnancy Prevention Methods P77 The Well Woman Visit Lecture: An Opportunity for Family Planning Education at a Faith-based Medical Institution P78 Do HIV-infected Women Want to Discuss Fertility Plans with Providers; and Are Those Conversations Occurring? P79 Integration of HIV Prevention and Reproductive Health Services P80 Social and Behavioral Impact of HIV/AIDS on Sudanese Patients After the Diagnosis P81 Does Salpingectomy Affect Ovarian Response with In Vitro Fertilization? P82 U USE IT (University Undergraduates’ Sexual Education—Investigating Teachings Survey) to Evaluate Sexual Health Education and Practice P83 Sexual Experiences of Young People in Uganda: Does Orphanhood Play a Role? P84 U USE IT (University Undergraduates’ Sexual Education—Investigating Teachings Survey) to Evaluate Students’ Perceptions of Virginity P85 Forced First Sex, Sexual Behavior and Sexually Transmitted Diseases among Women in Uganda P86 Implementing Patient-delivered Partner Therapy for Chlamydia Infection at an Urban Family Planning Clinic P87 The Inflammatory Effects of Two Vaginal Gels on the Reproductive Tract P88 Does Type of Underwear Worn Impact the Incidence of Non-sexually Transmitted Urogenital Infections? (The Thong Study) P89 What is the Extent of Family Planning Training in Family Medicine Residencies? P90 Human Decidual Macrophages Phagocytose Clostridium sordellii through Class A and B Scavenger Receptors P91 Defining Physician Advocacy for Adolescent Reproductive Health: Results from a Mixed Methods Study with Adolescent Medicine Physicians P92 Role and Relevance: Urban Adolescent Males, the Primary Care Provider and Provision of Confidential Care P93 Trends and Determinants of Reproductive Health Service Use among Young Women in the United States P94 Racial Differences in Attitudes towards Pregnancy and Motherhood in Teen and Young Women P95 Disseminating the HPV Vaccine to Women of Color: Implications for Reproductive Health P96 Attitude of Circumcised Sudanese Women towards Mutilating Their Daughters P97 Unintended Pregnancy in the United States at the State Level P98 Reproductive Health in Rural Sudan: A Population Based Survey P99 College Students’ Sexual Health: Behaviors, STD Testing and Prevention, and Pap Smear Knowledge Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 17 Special thanks to members of ARHP’s Corporate Advisory Board (CAB) for their commitment to high quality reproductive health care and support of ARHP’s Fund for the Future of Reproductive Health . Bayer HealthCare Pharmaceuticals Boehringer Ingelheim Pharmaceuticals, Inc. Depomed Duramed Pharmaceuticals, Inc., a subsidiary of Barr Pharmaceuticals, Inc. Endo Pharmaceuticals Ferring Pharmaceuticals Hologic LP Merck & Company, Inc. Ortho Women’s Health & Urology QIAGEN Schering-Plough Wyeth Pharmaceuticals ® fund future NAF ARHP 09 ad:Layout for 1the 8/14/2009 of reproductive health® the textbook of the The meeting for CAB representatives and the ARHP board of directors will take place Friday, October 2 from 12:30 to 2:00. We look forward to connecting with you for this annual dialogue on key issues 8:54 PM Page 1 that affect the field. Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care A state-of-the-art textbook that will serve as the standard, evidence-based reference text in abortion care Edited by: Maureen Paul, MD, MPH Planned Parenthood NYC, Mt. Sinai School of Medicine E. Steve Lichtenberg, MD, MPH Northwestern University School of Medicine Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care reviews the best surgical and medical practices for pregnancy termination, as well as managing ectopic and other abnormal pregnancies. Lynn Borgatta, MD, MPH Boston University School of Medicine David A. Grimes, MD University of North Carolina School of Medicine Phillip G. Stubblefield, MD Boston University School of Medicine Mitchell D. Creinin, MD University of Pittsburgh School of Medicine TO ORDER, VISIT NAF’S BOOTH IN THE EXHIBIT HALL OR: Call Toll-Free: 877.762.2974 (In Canada 800.567.4797) ISBN: 978-1-4051-7696-5 $134.95 Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 18 Order Online: www.wiley.com Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 19 1-877-4-EARLY OPTION www.earlyoptionpill.com your partner in reproductive health care. Danco Laboratories… V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV V VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV VV e lif ce vi ad up ok & fo in ex ys kl ee w ho : x: se 41 fo@ in ps p A ateventiohealth t g S pre al n sts i u x k r nte se o w o et e C ting l N lin rke h a i c On Ma alt o S l He a r Vi bile sites o eb : M e W ech or 0 g m T t 40 .or u S 9 c o 5. in M d 3 S Fin 5.8 isis t Aron & n e t i io -theducaomot f - o n , pr • • Deadline for submission 2010 Reproductive Health Education • Research • Advocacy Friday, February 26, 2010 11:59 pm ET Call for Abstracts 2010 September 22-25, 2010 • Hyatt Regency Atlanta • Atlanta, GA Reproductive Health Education • Research • Advocacy www.ReproductiveHealth2010.org 2010 Reproductive Health Education • Research • Advocacy Improving Women’s Health Through Disease Detection LabCorp is committed to providing accurate, timely results to assist in diagnosis, treatment, and management of health conditions. With an integrated network of regional laboratories and premier esoteric testing facilities, LabCorp offers a comprehensive menu of specialized and routine tests that address the health concerns of women through all life’s ages, phases, and stages. Please visit the LabCorp booth to learn more about our services and comprehensive Test Menu. ©2009 Laboratory Corporation of America® Holdings All rights reserved. L7410-0809 Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 20 Prevention and Early Detection Saves Lives Women’s Health Issues is a peer-reviewed, bimonthly, multidisciplinary journal that publishes research and review manuscripts related to women’s health care and policy. As the official journal of the Jacobs Institute of Women’s Health, the journal seeks to inform health services researchers, health care and public health professionals, social scientists, policymakers, and others concerned with women’s health. Please visit www.whijournal.com to subscribe or submit a manuscript for consideration. Free Special Supplement Issue Available Online: With support from the U.S. Centers for Disease Control and Prevention, WHI published a special issue on the topic of Policy & Financing Issues for Preconception and Interconception Health in 2008. This issue features peer-reviewed articles on topics such as: ▪ ▪ ▪ ▪ ▪ Private and public insurance coverage of women of reproductive age and preconception and interconception health care services; Public health data on the health of women of reproductive age and preconception and interconception health outcomes and health services; Impact on access to preconception and interconception care of programs, such as Healthy Start, community health centers, Title V, and family planning waivers; Quality and payment of preconception and interconception care services; Disparities in access to and quality of preconception and interception care by women of different ages, ethnic and racial backgrounds, and socioeconomic status. Visit http://whijournal.com/issues/contents?issue_key=S1049-3867(08)X0007-6 for free access. Jacobs Institute of Women’s Health 2021 K Street NW, Suite 800 Washington, DC 20006 (202) 994-4184; email: [email protected] www.jiwh.org NCCC Mission To help women, family members and caregivers battle the personal issues related to Cervical Cancer and HPV Remember: Vaccinate EARLY Pap Test REGULARLY HPV Test WHEN RECOMMENDED Call 800-685-5531 or visit our website www.nccc-online.org NCCC • ARHP • Program Ad • Mechanical • Renie Design 8 / 10 / 09 The Preferred Source We offer HyperRho Mini Dose & HyperRho Full Dose At a Great Price!! STOP by our booth, Mention this ad And be entered to WIN a great prize!! 1640 Roanoke Blvd Salem, VA 24153 (800)850-1657 We also offer a Whole line of Pharmaceuticals Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 21 Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 22 Let’s talk Essure The in-office solution for permanent birth control Highly effective – 99.74% efficacy rate at 5-year follow-up* Proven – 6+ years of commercial data, 250,000+ procedures, 170+ publications Easy – Micro-insert placed transcervically in an office setting High patient satisfaction – No incisions, no hormones, no slowing down *The five-year effectiveness was demonstrated in a portion of the women undergoing clinical studies. There continue to be no pregnancies to date among patients who had been enrolled in the Essure phase II and pivotal trials. www.essuremd.com Indications for use: The Essure procedure is used for women who desire permanent birth control (female sterilization) by bilateral occlusion of the fallopian tubes. Contraindications: If a patient is uncertain about her desire to end fertility; pregnant; has terminated or delivered less than 6 weeks before the Essure procedure; has an active or recent upper or lower pelvic infection. Warnings: The Essure procedure is not reversible, and is not suitable for all women. Cautions: Federal law restricts this device to sale by or on the order of a physician; should only be used by physicians who are knowledgeable hysteroscopists and have successfully completed the Essure training program. For a complete description of cautions, warnings, potential adverse events and contraindications see the Essure System Instructions for Use. ©2009 All rights reserved. Conceptus and Essure are registered trademarks and Your Family Is Complete Your Choice Is Clear is a service mark of Conceptus, Inc. CC-1945 11FEB09F Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 23 Committed to Women’s Healthcare Duramed Pharmaceuticals, an innovator in women’s healthcare pharmaceutical products, focuses its product development and marketing activities on products for women. Since its formation in 2001, Duramed has steadily grown to over 400 employees, 25 marketed products, aggressive corporate development activities, and over a dozen R&D projects in various stages of development. Duramed Pharmaceuticals, Inc. is the U.S. proprietary (branded) pharmaceutical subsidiary of Barr Pharmaceuticals, Inc., a global specialty pharmaceutical company that operates in more than 30 countries. For more information visit our website at www.barrlabs.com Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 24 ADS-00127-001Rev001_ARHP_Reva.qxd:Layout 1 7/30/09 11:49 AM Page 1 We want women everywhere to live longer, stronger, healthier lives. Breast Imaging • Cervical Cancer Screening Molecular Diagnostics • Osteoporosis Assessment Permanent Contraception • Endometrial Ablation Prenatal Health ADS-00127-001 Rev 001 Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 25 Cultivating a collaborative and supportive environment to foster scholarly activity and leadership in the areas of reproductive health and family planning. Join us! Help shape the Society and help shape the field. Benefit from SFP research grants, opportunities to network with like-minded colleagues and to be exposed to the latest in family planning research, a subscription to Contraception, and the chance to participate in Society committees. “SFP funded my first foray into basic science research. As a young clinical investigator at an early stage in my career, this was a tremendous opportunity for me to develop skills under close mentorship and to approach clinical research questions from new angles.” —Alison Edelman, MD, MPH SFP Membership is open to any qualified individual in good professional standing who has an interest in family planning demonstrated through post-doctoral training, a substantial clinical or laboratory practice, or academic presentations and publications within this field. To learn more and apply online: www.societyfp.org sfp4-09.indd 1 Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 26 7/30/09 1:51 PM Every year, Planned Parenthood® affiliate health centers provide millions of women, men, and teens with a broad range of sexual and reproductive health services and information, including medically accurate sex education, contraception and abortion services, cervical and breast cancer screening, and testing and treatment for sexually transmitted infections. We commend the women and men who provide care to Planned Parenthood clients in more than 850 affiliate health centers and the members of the PPFA National Medical Committee for volunteering their time in support of PPFA. Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 27 Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 28 online tools for reproductive health students, faculty, and providers Use this interactive resource to discover unique reproductive health training opportunities around the world. Explore this dynamic teaching tool to build presentations from an open-access library of peer-reviewed slides, handouts, and learning activities. These tools and more are available at www.arhp.org Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 29 Stewart Center East & West Community Space for Reproductive Health and Justice Honor a legend by investing in the future of reproductive health and justice Help ARHP & ANSIRH provide free, cutting-edge community meeting space for reproductive health and rights work by contributing to the Felicia Stewart Center. Through your generosity, Dr. Stewart’s legacy will live on in community activism, high–quality research, provider education, and reproductive justice. Please help us honor Dr. Stewart’s vision by giving generously at: www.arhp.org/FeliciaStewartCenter Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 30 Let’s Talk < < < < < < < < < < < < < < < < September 30 – october 2 Booth 1 Female Sexual DySFunction (FSD) including HyPoactiVe Sexual DeSiRe DiSoRDeR (HSDD) Virtual OL Presentation on FSD and HSDD Interactive Learning Stations including Data, Videos, and Learning Tool Neurobiology Video of FSD FSD Disease Awareness Survey Copyright © 2009, Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved. SD66461 Reproductive Health 2009 | September 30 — October 3, 2009 | Los Angeles, CA | 31 Reproductive Health Education • Research • Advocacy Save The Date 2010 Reproductive Health E d u c a t i o n • 22-25, R e s e a r c2010 h • A d v• o c a Hyatt cy September Regency Atlanta • Atlanta, GA 2010 Reproductive Health Education • Research • Advocacy 2010 Reproductive Health Education • Research • Advocacy 2010 Reproductive Health Education • Research • Advocacy www.reproductiveHealth2010.org